Initial In-Hospital Management of Hematemesis and Melena
The initial in-hospital management for patients presenting with hematemesis and melena should prioritize aggressive volume resuscitation, hemodynamic stabilization, and blood transfusion to maintain hemoglobin above 7g/dL, followed by urgent endoscopic evaluation within 24 hours.1
Immediate Resuscitation Phase
Hemodynamic Stabilization
- Establish IV access with two large-bore IV catheters
- Fluid resuscitation:
- Begin with crystalloid boluses to normalize blood pressure and heart rate
- Target normalization of vital signs (systolic BP >100 mmHg, heart rate <100 bpm)
- Monitor urine output and central venous pressure when appropriate 1
Blood Product Management
- Blood transfusion threshold: Maintain hemoglobin >7g/dL
- Higher threshold of 9g/dL for patients with:
- Massive bleeding
- Significant cardiovascular comorbidities
- Anticipated delays in therapeutic interventions 1
Initial Assessment
- Insert nasogastric tube to:
- Protect airway
- Decompress stomach
- Assess ongoing bleeding (note: 3-16% of patients with UGIB may have negative aspirate) 1
- Continuous monitoring of:
- Vital signs
- Urine output
- Serial hemoglobin measurements 1
Pharmacological Management
Proton Pump Inhibitor Therapy
- Initiate high-dose IV omeprazole: 80mg bolus followed by 8mg/hour continuous infusion for 72 hours 1
- This regimen has been shown to reduce:
- Rate of rebleeding
- Blood transfusion requirements
- Duration of hospital stay 1
Other Medications
- Somatostatin: Despite theoretical benefits, insufficient evidence for routine use 1
- Tranexamic acid: May reduce surgical intervention but insufficient evidence for routine recommendation 1
Diagnostic Approach
Timing of Endoscopy
- Urgent endoscopy (within 24 hours of admission) is recommended as the first-line diagnostic and therapeutic procedure 1
- Patients with ongoing hemodynamic instability despite resuscitation may require more immediate endoscopy 1
Endoscopy Setting
- Best performed in a fully equipped endoscopy unit with:
- Trained nursing staff
- Equipment for cardiorespiratory monitoring
- Therapeutic capabilities 1
- For unstable patients or after-hours procedures, consider operating theater setting with anesthesia support 1
Post-Endoscopy Management
Monitoring for Rebleeding
- Close observation with continuous monitoring of:
- Pulse
- Blood pressure
- Urine output 1
- Signs of rebleeding include:
- Fresh hematemesis or melena
- Fall in blood pressure
- Rise in pulse rate
- Drop in central venous pressure 1
Diet Considerations
- Patients who are hemodynamically stable 4-6 hours after endoscopy can start drinking and eating a light diet 1
Repeat Endoscopy Indications
- Clinical evidence of active rebleeding
- Concerns about suboptimal initial endoscopic therapy 1
Common Pitfalls and Caveats
- Delayed resuscitation: Prioritize volume resuscitation before diagnostic procedures in unstable patients
- Over-transfusion: Avoid excessive transfusion beyond hemoglobin targets as it may increase portal pressure and worsen bleeding
- Delayed endoscopy: Failure to perform timely endoscopy can lead to missed therapeutic opportunities
- Inadequate PPI dosing: Standard PPI dosing is insufficient; high-dose regimen is required
- Failure to monitor: Continuous monitoring is essential as 15-20% of patients may rebleed after initial stabilization
By following this algorithmic approach to the management of hematemesis and melena, clinicians can optimize outcomes by addressing the immediate life-threatening aspects of bleeding while preparing for definitive diagnosis and treatment.